Involvement of leukotriene B4 in arthritis models

Life Sciences

Volumn 64, Issue 3, 1998, Pages

  Tsuji, Fumio ^a   Oki, Kenji ^a   Fujisawa, Koushi ^a   Okahara, Akihiko ^a   Horiuchi, Masato ^a   Mita, Shiro ^a  

^a SANTEN PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Collagen induced arthritis; Hydrolase inhibitor; Leukotriene A4; Leukotriene B4; MDP induced arthritis; SA6541; Synovial stromal cell

Indexed keywords

4 DIMETHYLAMINOBENZYL N (3 MERCAPTO 2 METHYLPROPIONYL)CYSTEINE; BUCILLAMINE; ENZYME INHIBITOR; LEUKOTRIENE A4 HYDROLASE; LEUKOTRIENE B4; SA 6541; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; INFLAMMATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; SYNOVIOCYTE;

ANIMALIA; MURINAE;

EID: 0032509197     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00556-6     Document Type: Article

References (20)

1. 1. A.W. FORD-HUTCHINSON, Immunology 10 1-12 (1990).
2. 2. A.W. FORD-HUTCHINSON, M.A. BRAY, M.V. DOIG, M.E. SHIPLEY and M.J.H. SMITH, Nature 286 264-265 (1980).
3. 3. E.M. DAVIDSON, S.A. RAE and M.J.H. SMITH, Ann. Rheum. Dis. 42 677-679 (1983).
4. 4. D. SCHRIER, R.B. GILBERTSEN, M.L. LESCH and J. FANTONE, Am. J. Pathol. 117 26-29 (1984).
5. 5. W.P. AREND and J.M. DAYER, Arthritis Rheum. 33 305-315 (1990).
6. 6. T.E. CAWSTON and C. BILLINGTON, J. Pathol. 180 115-117 (1996).
7. 7. R.J. GRIFFITHS, E.R. PETTIPHER, K. KOCH, C.A. FARRELL, R. BRESLOW, M.J. CONNKYN, M.A. SMITH, B.C. HACKMAN, D.J. WIMBERLY, A.J. MILICI, D.N. SCAMPOLI, J.B. CHENG, J.S. PILLAR, C.J. PAZOLES, N.S. DOHERTY, L.S. MELVIN, L.A. REITER, M.S. BIGGARS, F.C. FALKNER, D.Y. MITCHELL, T.E. LISTON and H.J. SHOWELL, Proc. Natl. Acad. Sci. USA 92 517-521 (1995).
8. 8. A. ANDREASEN, E.S. HANSEN, K. FOGH, K. KRAGBELLE and T. HERLIN, APMIS 98 605-608 (1990).
9. 9. F. TSUJI, Y. MIYAKE, M. HORIUCHI and S. MITA, Biochem. Pharmacol. 55 297-304 (1998).
10. 10. F. TSUJI, Y. MIYAKE, H. ENOMOTO, M. HORIUCHI and S. MITA, Eur. J. Pharmacol. 346 81-85 (1998).
11. 11. H. AONO, T. HASUNUMA, K. FUJISAWA, T. NAKAJIMA, K. YAMAMOTO, S. MITA and K. NISHIOKA, J. Rheumatol. 22 65-70 (1995).
12. 12. N. OHISHI, T. IZUMI, Y. SEYAMA and T. SHIMIZU, Methods in Enzymology 187 286-295 (1990).
13. 13. J.S. COURTENAY, B. MOSEDALE, Nature 283 666-668 (1980).
14. 14. S. BITTNER and K. WIELCKENS, Endocrinology 123 991-1000 (1988).
15. 15. D.S. SNYDER, R. CASTRO and J.F. DESFORGES, Exp. Hematol. 17 6-9 (1989).
16. 16. D. ATLURU, S. GUDAPATY, M.P. O'DONNELL and G.E. Woloschak, J. Leukoc. Biol. 54 269-274 (1993).
17. 17. S. TAM, S.L. HONG and L. LEVINE, J. Pharmacol. Exp. Ther. 203 162-168 (1977).
18. 18. J. HUWYLER, M. BÜRGIN, T. ZEUGIN and J. GUT, Mol. Pharmacol. 39 314-323 (1991).
19. 19. C.N. SERHAN, Nature 384 23-24 (1996).
20. 20. P.R. DEVCHAND, H. KELLER, J.M. PETERS, M. VAZQUEZ, F.J. GONZALEZ and W. WAHLI, Nature 384 39-43 (1996).